Chimerix (CMRX) director Multani received 60,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Pratik S Multani (director at Chimerix Inc., CMRX) reported that they received 60,000 Stock Option (Right to Buy) on Jun 20, 2024.
- Reporting person
- Multani Pratik S
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | Grant or award (A) | Stock Option (Right to Buy)On 60,000 Common Stock1 | +60,000 | - | - | 60,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 60,000 direct
Footnotes from the filing
- 1. The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2024 annual stockholder meeting.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Multani report in this CMRX Form 4?
Pratik S Multani (director at Chimerix Inc., CMRX) reported that they received 60,000 Stock Option (Right to Buy) on Jun 20, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CMRX
Earlier insider filings at CMRX
- Jun 21, 2024SEC Form 4 filed by Director Middleton Fred A
- Jun 21, 2024SEC Form 4 filed by Director Meyer Robert J.
- Jun 21, 2024SEC Form 4 filed by Director Kozin Marc D
- Jun 21, 2024SEC Form 4 filed by Director Decker Lisa Lynn
- Jun 21, 2024SEC Form 4 filed by Director Demski Martha J
Keep researching CMRX
- CMRX insider tradesEvery buy and sale reported by Chimerix Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
CMRX
Chimerix Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2013
Get push alerts for CMRX
Full CMRX profile on Quantisnow Follow CMRX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time